Inventor

Samuel Achilefu

Inventor

St. Louis, MO, US

Overview

2000–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes34%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%

C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments16%

C07DHeterocyclic compounds14%

C07KPeptides3%

A61BDiagnosis2%

B82YSpecific uses or applications of nanostructures2%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%

C01FCompounds of the metals beryllium, magnesium, aluminium, calcium, strontium, barium, radium, thorium, or of the rare-earth metals1%

C01PIndexing scheme relating to structural and physical aspects of solid inorganic compounds1%

PatentTitleYear

11,052,163Homing agents2021 10,806,804Compounds having RD targeting motifs and methods of use thereof2020 10,639,327Nano-calcium carbonate2020 8,658,433'Dye compounds as photoactive agents'2014 8,344,158'Fluorescent polymethine cyanine dyes'2013 8,318,133'Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications'2012 8,053,415'Compounds having RD targeting motifs'2011 7,850,946'Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications'2010 7,790,144'Receptor-avid exogenous optical contrast and therapeutic agents'2010 7,767,194'Optical diagnostic and therapeutic agents and compositions'2010 7,758,861'Dye-sulfenates for dual phototherapy'2010 7,608,244'Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients'2009 7,566,444'Versatile hydrophilic dyes'2009 7,556,797'Minimally invasive physiological function monitoring agents'2009 7,514,069'Tumor-targeted optical contrast agents'2009 7,510,700'Pathological tissue detection and treatment employing targeted benzoindole optical agents'2009 7,504,087'Receptor-avid exogenous optical contrast and therapeutic agents'2009 7,468,177'Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients'2008 7,438,894'Dyes for organ function monitoring'2008 7,431,925'Internal image antibodies for optical imaging and therapy'2008 7,427,657'Aromatic sulfenates for type 1 phototherapy'2008 7,351,807'Cyanine-sulfenates for dual phototherapy'2008 7,303,926'Methods and compositions for dual phototherapy'2007 7,297,325'Hydrophilic light absorbing compositions for determination of physiological function'2007 7,252,815'Pathological tissue detection and treatment employing targeted benzoindole optical agents'2007 7,235,685'Aromatic sulfenates for type I phototherapy'2007 7,230,088'Compounds for dual photodiagnosis and therapy'2007 7,201,892'Pathological tissue detection and treatment employing targeted optical agents'2007 7,198,778'Tumor-targeted optical contrast agents'2007 7,175,831'Light sensitive compounds for instant determination of organ function'2007 7,128,896'Pathological tissue detection and treatment employing targeted benzoindole optical agents'2006 7,011,817'Hydrophilic cyanine dyes'2006 6,939,532'Versatile hydrophilic dyes'2005 6,887,854'Compounds as dynamic organ function monitoring agents'2005 6,761,878'Pathological tissue detection and treatment employing targeted benzoindole optical agents'2004 6,747,151'Azo compounds for type I phototherapy'2004 6,733,744'Indole compounds as minimally invasive physiological function monitoring agents'2004 6,716,413'Indole compounds as tissue-specific exogenous optical agents'2004 6,706,254'Receptor-avid exogenous optical contrast and therapeutic agents'2004 6,673,334'Light sensitive compounds for instant determination of organ function'2004 6,669,926'Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients'2003 6,663,847'Dynamic organ function monitoring agents'2003 6,656,451'Indole compounds as novel dyes for organ function monitoring'2003 6,641,798'Tumor-targeted optical contrast agents'2003 6,485,704'Azo compound for type I pototherapy'2002 6,423,547'Non-covalent bioconjugates useful for diagnosis and therapy'2002 6,395,257'Dendrimer precursor dyes for imaging'2002 6,280,703'Simultaneous multimodal measurement of physiological function'2001 6,277,841'Quinoline ligands and metal complexes for diagnosis and therapy'2001 6,264,919'Indocyanine dyes'2001 6,264,920'Tunable indocyanine dyes for biomedical applications'2001 6,228,344'Method of measuring physiological function'2001 6,217,848'Cyanine and indocyanine dye bioconjugates for biomedical applications'2001 6,190,641'Indocyanine dyes'2001 6,183,726'Versatile hydrophilic dyes'2001 6,180,085'Dyes'2001 6,180,087'Tunable indocyanine dyes for biomedical applications'2001 6,180,086'Hydrophilic cyanine dyes'2001 6,013,243'Gaseous inhalable ultrasound contrast agents and method therefor'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2010Patents assigned to MALLINCKRODT INC (49)· patent assignee history

2000–2021Based in St. Louis, MO, US· patent location history

2001Based in Bridgeton, MO, US· patent location history

2010–2012Patents assigned to UNIV ST LOUIS (3)· patent assignee history

2012–2013Patents assigned to ACHILEFU SAMUEL (2)· patent assignee history

2013–2021Patents assigned to UNIV WASHINGTON (4)· patent assignee history

2014–2021Patents assigned to ACHILEFU SAMUEL I (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MALLINCKRODT INC	49	2000–2010
UNIV WASHINGTON	4	2013–2021
UNIV ST LOUIS	3	2010–2012
ACHILEFU SAMUELself	2	2012–2013
ACHILEFU SAMUEL Iself	2	2014–2021

Locations

Location	Patents	Span
St. Louis, MO, US	57	2000–2021
Bridgeton, MO, US	2	2001